MACK DAVID J. - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 31, 2025, MACK DAVID J.'s relationship to BioXcel Therapeutics, Inc. (BTAI) is Director, and currently has 20,317 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BTAI insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
MACK DAVID J. - Insider Non-Derivative Transactions of BTAI Common Stock
MACK DAVID J. - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Nov 1, 2025 M -- (Common Stock) 1694 0 20317
Oct 1, 2025 M -- (Common Stock) 1694 0 18623
Sep 1, 2025 M -- (Common Stock) 1693 0 16930
Aug 1, 2025 M -- (Common Stock) 1693 0 15237
Jul 1, 2025 M -- (Common Stock) 1693 0 13544
Jun 1, 2025 M -- (Common Stock) 1693 0 11851
May 1, 2025 M -- (Common Stock) 1693 0 10158
Apr 1, 2025 M -- (Common Stock) 1693 0 8465
Mar 1, 2025 M -- (Common Stock) 1693 0 6772
Feb 1, 2025 M -- (Common Stock) 27089 0 81267
Jan 1, 2025 M -- (Common Stock) 27089 0 54178
Dec 1, 2024 M -- (Common Stock) 27089 0 27089